CNTG's logo.
Ticker Symbol: CNTG

Centogene NV

$9.80 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: Germany Currency: USD Asset Type: Common Stock CIK:0001757097

Company Profile

centogene is a worldwide leader in the field of genetic diagnostic testing for rare hereditary diseases, with a broad test portfolio covering over 2800 genes, biochemical tests, biomarker tests, clinical whole exome sequencing and whole genome sequencing. centogene’s mission is to support medical professionals with in-depth medical expertise in order to diagnose early the cause of the patients’ symptoms. analyzing samples from all over the world allows centogene to constantly expand its unique portfolio resulting in the largest systematic documentation of genetic results, centomd®. this mutation database integrates genetic and clinical information, enabling the highest quality, knowledge-based genetic testing and biomarker development. in addition to offering diagnostic services for individual patients, centogene is a pivotal partner to some of the most respected names in the industry. imprint centogene ag is a stock corporation ('aktiengesellschaft') incorporated under the

Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 8071
Address: Am Strande 7
CEO: N/A
Tags:
  • Commercial Services
  • Miscellaneous Commercial Services

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $1.04
Change: -$0.01 ( -0.95%)
Days Range: $1.04 - $1.05
Beta: -0.46
52wk. High: $2.52
52wk. Low: $0.61
Ytd. Change 11.95%
50 Day Moving Average: $1.06
200 Day Moving Average: $1.00
Shares Outstanding: 27595835

Valuation

Market Cap: 2.9B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A